PHR catalysts
Catalysts and events linked to PHR, newest first.
PHR stock catalysts and risks
Latest published review: 2026-10-20
| Development | Transmission channel | Evidence | Condition to watch |
|---|---|---|---|
| Phreesia Falls 6.3% on Q2 Net Income Shortfall Despite 10% Revenue Growth to $129.5M 2026-09-04 · Down | net income margin miss on healthcare SaaS valuation multiple | Phreesia dropped 6.33% after reporting Q2 net income of $1.9 million ($0.03/share), missing expectations. | Not recorded |
| Phreesia falls 6.3% after Q2 net income misses expectations 2026-09-04 · Down | operating margin compression and net earnings shortfall | Phreesia stock dropped 6.33% after Q2 net income missed estimates. | Not recorded |
Do these developments change your position?
Review PHR alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
DateCardAvg 5d
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.